triazoles has been researched along with Amyotonia Congenita in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bottino, C; Caretti, G; Filippakopoulos, P; Fittipaldi, R; Mamchaoui, K; Nevi, L; Segatto, M; Szokoll, R | 1 |
Amrein, C; Bergé, MM; Billaud, EM; Boussaud, V; Chevalier, P; Daudet, N; Guillemain, R; Le Beller, C; Lillo-Le Louet, A | 1 |
2 other study(ies) available for triazoles and Amyotonia Congenita
Article | Year |
---|---|
BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy.
Topics: Animals; Azepines; Disease Models, Animal; Inflammation; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NADP; NADPH Oxidases; Neuromuscular Diseases; Nuclear Proteins; Oxidative Stress; Reactive Oxygen Species; Transcription Factors; Triazoles | 2020 |
Neuromuscular painful disorders: a rare side effect of voriconazole in lung transplant patients under tacrolimus.
Topics: Adolescent; Adult; Aspergillosis; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Lung Transplantation; Male; Middle Aged; Neuromuscular Diseases; Pain; Postoperative Complications; Pyrimidines; Retrospective Studies; Risk Assessment; Severity of Illness Index; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole | 2008 |